NCT05426356 (SAFFRON) is a NA clinical trial of Surgical Intervention in Fracture;Pelvis, sponsored by SI-BONE, Inc..

Who is sponsoring NCT05426356?

NCT05426356 is sponsored by SI-BONE, Inc..

What drugs are being tested in NCT05426356?

Interventions in NCT05426356: Surgical Intervention, Non-Surgical Management.

What condition does NCT05426356 study?

NCT05426356 studies Fracture;Pelvis, Sacral Fracture, Sacroiliac; Fusion, Fragility Fracture, Insufficiency Fractures, Osteoporosis.

Is NCT05426356 still recruiting?

NCT05426356 is currently terminated. Last updated 24 October 2024.

Last reviewed 2024-10-24 · How we verify

NCT05426356: SAFFRON

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sacral Fracture Fusion/Fixation for Rapid Rehabilitation

Terminated NA Last updated 24 October 2024

What this trial tests

NA trial testing Surgical Intervention in Fracture;Pelvis in 28 participants. Terminated before completion.

Timeline

18 September 2022

Primary endpoint
15 June 2024

15 June 2024

Quick facts

Lead sponsor	SI-BONE, Inc.
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	28
Start date	18 September 2022
Primary completion	15 June 2024
Estimated completion	15 June 2024
Sites	7 locations across United States

Drugs / interventions tested

Surgical Intervention
Non-Surgical Management

Conditions studied

Fracture;Pelvis — all drugs for Fracture;Pelvis →
Sacral Fracture — all drugs for Sacral Fracture →
Sacroiliac; Fusion — all drugs for Sacroiliac; Fusion →
Fragility Fracture — all drugs for Fragility Fracture →

Sponsor

SI-BONE, Inc. — full company profile →

Who can join

60 and older, any sex, with Fracture;Pelvis or Sacral Fracture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To determine the safety and efficacy of concomitant sacral fracture fixation and sacroiliac (SI) joint fusion vs. non-surgical management for patients with debilitating sacral fragility or insufficiency fractures

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Surgical Intervention

Trials testing the same drug.

NCT06578871 — Surgery and Reducing Ionizing Radiation of the Unknown Primary · Phase 2 · not yet recruiting
NCT06512779 — Developing a Treatment Clustering System for Obstructive Sleep Apnea Using Polysomnographic Physiological Signals · NA · recruiting

Other SI-BONE, Inc. trials

Trials by the same sponsor.

NCT04062630 — SI Joint Stabilization in Long Fusion to the Pelvis · NA · completed
NCT03122899 — Study of Bone Growth in the Sacroiliac Joint After Minimally Invasive Surgery With Titanium Implants · NA · completed
NCT01874236 — Validity and Reliability of Diagnostic Findings of SI Joint Blocking · Phase 4 · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05426356 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by SI-BONE, Inc.
Last refreshed: 24 October 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05426356.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing